Ananchuensook, Prooksa
Sriphoosanaphan, Supachaya
Suksawatamnauy, Sirinporn
Siripon, Nipaporn
Pinjaroen, Nutcha
Geratikornsupuk, Nopavut
Kerr, Stephen J.
Thanapirom, Kessarin
Komolmit, Piyawat
Funding for this research was provided by:
Ratchadaphiseksomphot Endowment Fund (RCU_H_64_023_30)
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (RA64/026)
Ratchadaphiseksomphot Endowment Fund of hepatic fibrosis and cirrhosis
Article History
Received: 24 March 2022
Accepted: 2 June 2022
First Online: 14 June 2022
Declarations
:
: The study was reviewed and approved by the Ethics Committee and Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB Number: 467/64). Informed consent was waived because of the retrospective nature of the study and the Ethics Committee and Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB Number: 467/64) also approved the informed consent waiver. All the study protocol was in accordance with Declaration of Helsinki (1989) of the World Medical Association.
: The authors declare that they have no competing interests.